INTERNATIONAL PATENT: ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD., 浙江扬厉医药技术有限公司 FILES APPLICATION FOR "HETEROCYCLIC SUBSTITUTED SULFONAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE"

GENEVA, Feb. 8 -- ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 1106, Building 1, Haozhang Plaza, Gongshu DistrictHangzhou, Zhejiang 310024), 浙江扬厉医药技术有限公司 (中国浙江省杭州市拱墅区皓章大厦1幢1106室) filed a patent application (PCT/CN2025/111188) for "HETEROCYCLIC SUBSTITUTED SULFONAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE" on Jul 29, 2025. With publication no. WO/2026/026768, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International P...